Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor ‐related hematological adverse events

This study summarizes the manifestations of hematological irAEs and proposes preliminary recommendations for diagnosis and treatment.What this study adds• Much still remains unknown regarding hematological irAEs caused by checkpoint inhibitors. This study delineates the overview of hematological irAEs, and provides practical treatment suggestions, in particular addressing the issue of rechallenge.

Source: Thoracic Cancer - February 4, 2020 Category: Cancer & Oncology Authors: Junling Zhuang, Jianhua Du, Xiaoxiao Guo, Jiaxin Zhou, Lian Duan, Wei Qiu, Xiaoyan Si, Li Zhang, Yue Li, Xiaowei Liu, Hanping Wang, Daobin Zhou, Li Zhang Tags: CLINICAL GUIDELINE Source Type: research